Cancer treatments have advanced dramatically over the years. It is increasingly important to understand the molecular features of a cancer when the diagnosis is made in order to allow oncologists to chart an optimal treatment path. Whether you’ve recently started on treatment, or are seeking new treatment options, we’d like to partner with you and your oncologist to explore options to potentially better treat your specific cancer.
Knowing what cancer looks like at the molecular level may lead to better treatment options. Regardless of where a tumor is located, its molecular composition tells doctors a lot about how the cancer may behave and what treatments may be most effective. The science behind molecular profiling has made significant progress in recent years, and physicians can now better match your cancer’s biomarkers to a specific treatment, increasing the probability that you’ll have a positive outcome.
Because no two tumors are alike, it is imperative to have the most advanced treatment assessment available when making decisions about an individual patient. The Caris molecular profiling report can identify molecular changes – or biomarkers – in your tumor that provide invaluable information on whether your tumor may or may not respond to specific drugs or if you are a potential candidate for clinical trials.
Caris molecular profiling performs thorough molecular testing on DNA, RNA and proteins to identify the biomarkers in your tumor that provide relevant information for optimized treatment decisions, while also comparing the biomarkers with data from clinical studies around the world. This is a powerful asset to aid clinical decisions regarding individual cancer therapies.
Caris molecular profiling enables clinicians to:
Your oncologist will discuss available treatment options that are frequently based on large studies and have been established as standard of care. These treatment options increasingly require knowledge about biomarkers in your individual case. Beyond that, molecular studies can guide the way toward individualized treatments beyond the standard of care and assist in identifying clinical trials that match your cancer’s profile.
While patients cannot order a test without their physician, healthcare providers can easily order a Caris Molecular Intelligence test online, by email, or via fax. Once the requisition form is completed, Caris receives the necessary documents and tumor samples to complete the testing.